Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bc8cb1f4d0c06b0f289772d1d6aca9916> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bc8cb1f4d0c06b0f289772d1d6aca9916 NCIT_P378 "NCI" @default.
- Bc8cb1f4d0c06b0f289772d1d6aca9916 type Axiom @default.
- Bc8cb1f4d0c06b0f289772d1d6aca9916 annotatedProperty IAO_0000115 @default.
- Bc8cb1f4d0c06b0f289772d1d6aca9916 annotatedSource NCIT_C173850 @default.
- Bc8cb1f4d0c06b0f289772d1d6aca9916 annotatedTarget "A recombinant protein-based vaccine composed of a recombinant spike (S) protein receptor-binding domain (RBD)-dimer, produced in Chinese hamster ovary (CHO) cells, of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), with potential immunomodulating and anti-coronavirus disease 2019 (COVID-19) activities. Upon intramuscular administration of the recombinant S-protein RBD-dimer SARS-CoV-2 vaccine, the S protein RBD-dimer activates the immune system to create anti-SARS-CoV-2 S protein antibodies. The antibodies recognize and neutralize the S protein and kill SARS-CoV-2. This prevents SARS-CoV-2 infection. S-protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus. The dimeric form of SARS-CoV-2 RBD may increase its immunogenicity." @default.